Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2007Cancer ResearchOpen Access

Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2

View Full Paper
Ask AI
Bookmark
Share

Authors

CHChristine E. HorakUniversité Paris-SudJLJong‐Heun LeeBoston UniversityAEAbdel ElkahlounNational Institutes of Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Horak et al. (2007) studied this question.

synapsesocial.com/papers/6a9ab210cc0ca3339d0e5ddehttps://doi.org/10.1158/0008-5472.can-07-0962
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evidence for a Novel Gene Associated With Low Tumor Metastatic Potential1988 · 1,342 citations
  2. 2Nm23-H1 Metastasis Suppressor Expression Level Influences the Binding Properties, Stability, and Function of the Kinase Suppressor of Ras1 (KSR1) Erk Scaffold in Breast Carcinoma Cells2005 · 75 citations
  3. 3The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases2006 · 215 citations
  4. 4Decreased expression of nucleoside diphosphate kinase α isoform, annm23-H2 gene homolog, is associated with metastatic potential of rat mammary-adenocarcinoma cells1996 · 68 citations